Short-term mortality among patients with non–small cell lung cancer and respiratory failure: a retrospective study


Submitted: 9 April 2011
Accepted: 9 June 2011
Published: 28 June 2011
Abstract Views: 971
PDF: 1085
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Boris Medarov Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Keck School of Medicine, University of Southern California, United States.
  • Tejo Ramam Challa Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Keck School of Medicine, University of Southern California, United States.
Lung cancer remains the number one cause of malignancy-related mortality in the United States. Identifying risk factors that are predictive of short-term mortality among patients with non-small cell lung cancer will allow the patients, their families and health care providers to be better prepared emotionally for the fatal outcome and may attenuate the cost and distress associated with often futile measures. The objective of this study was to measure the 3-month mortality among patients with non-small cell lung cancer who developed respiratory failure. This retrospective study reviewed the outcome of all patients with inoperable non-small cell lung cancer who were admitted to our hospital with respiratory failure. Respiratory failure was defined as need for mechanical ventilation, noninvasive ventilation, or at least 50% fraction of inspired oxygen. Short-term mortality was defined as death in the hospital or within 3 months of discharge, as well as discharge to hospice; shortterm mortality was found to be 94.4% in the study population. The prognosis of patients with inoperable non-small cell lung cancer and respiratory failure is grave. Short-term mortality among this patient population is close to 100%.

Boris Medarov, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Keck School of Medicine, University of Southern California

Assistant Professor of Clinical Medicine

Division of Pulmonary and Critical Care Medicine

Department of Internal Medicine

Tejo Ramam Challa, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Keck School of Medicine, University of Southern California

Research Fellow
Division of Pulmonary and Critical Care Medicine
Department of Internal Medicine

Medarov, B., & Challa, T. R. (2011). Short-term mortality among patients with non–small cell lung cancer and respiratory failure: a retrospective study. Chest Disease Reports, 1(1), e7. https://doi.org/10.4081/cdr.1.3

Downloads

Download data is not yet available.

Citations